India Women’s Health Market Size & Outlook, 2023-2030
India women’s health market, 2018-2030 (US$M)
Related Markets
India women’s health market highlights
- The India women’s health market generated a revenue of USD 1,450.4 million in 2023 and is expected to reach USD 2,508.3 million by 2030.
- The India market is expected to grow at a CAGR of 8.1% from 2024 to 2030.
- In terms of segment, contraceptives was the largest revenue generating application in 2023.
- Endometriosis & Uterine Fibroids is the most lucrative application segment registering the fastest growth during the forecast period.
Women’s health market data book summary
| Market revenue in 2023 | USD 1,450.4 million |
| Market revenue in 2030 | USD 2,508.3 million |
| Growth rate | 8.1% (CAGR from 2023 to 2030) |
| Largest segment | Contraceptives |
| Fastest growing segment | Endometriosis & Uterine Fibroids |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Hormonal Infertility, Contraceptives, Postmenopausal Osteoporosis, Endometriosis & Uterine Fibroids, Menopause, Polycystic Ovary Syndrome (PCOS) |
| Key market players worldwide | AbbVie Inc, Bayer AG, Merck & Co Inc, Pfizer Inc, Teva Pharmaceutical Industries Ltd, Agile Therapeutics Inc, Amgen Inc, Apothecus, Blairex Laboratories, Ferring |
Other key industry trends
- In terms of revenue, India accounted for 3.3% of the global women’s health market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Asia Pacific, Japan women’s health market is projected to lead the regional market in terms of revenue in 2030.
- China is the fastest growing regional market in Asia Pacific and is projected to reach USD 3,966.1 million by 2030.
Contraceptives was the largest segment with a revenue share of 41.53% in 2023. Horizon Databook has segmented the India women’s health market based on hormonal infertility, contraceptives, postmenopausal osteoporosis, endometriosis & uterine fibroids, menopause, polycystic ovary syndrome (pcos) covering the revenue growth of each sub-segment from 2018 to 2030.
India is one of the lucrative markets for women’s health owing to high unmet needs, large patient base, increasing awareness among people, and favorable government initiatives undertaken by government bodies. Moreover, increasing prevalence of target diseases and associated health conditions are supporting the market growth.
According to a report published by the International Journal of Research in Ortho paedics in April 2021, the prevalence of osteoporosis was 19.4% among women aged above 50 years in India. Moreover, anemia among Indian women of reproductive age is one of the highest rates (53%) in the world, which increases the risk of other severe conditions in women.
In addition, the condition affects approximately two-thirds of all pregnant women. The prevalence of anemia among pregnant women and nonpregnant women in the country was approximately 50.3% and 53.2%, respectively, in 2018. Such a high prevalence of anemia is boosting the growth of women’s health market in India.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Women’s Health Market Scope
Women’s Health Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
India women’s health market size, by application, 2018-2030 (US$M)
India Women’s Health Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
